Lorillard Tobacco Company Statement Regarding FDA Panel Public Meeting
GREENSBORO, N.C., March 30 /PRNewswire/ -- Lorillard Tobacco Company today issued the following statement regarding the Food and Drug Administration's Tobacco Products Scientific Advisory Committee (TPSAC) which is holding its first public meeting this week. This statement can be attributed to Dr. Bill True, Senior Vice President.
"The FDA's scientific advisory committee will be looking at many aspects of regulation but one major challenge will be for committee members to remain focused on an objective analysis of the science surrounding menthol.
"Menthol, obviously, has been used for decades in food, drink, cosmetics and other products. And the science is clear and compelling that there is no differing health risk between menthol and non-menthol products.
"With respect to public health, using the best methods available to science, it is clear a menthol cigarette is just another cigarette and should be treated no differently."
About Lorillard, Inc.
Lorillard, Inc. (NYSE: LO) is the third largest manufacturer of cigarettes in the United States. Founded in 1760, Lorillard is the oldest continuously operating tobacco company in the U.S. Newport®, Lorillard's flagship menthol-flavored premium cigarette brand, is the top selling menthol and second largest selling cigarette in the U.S. In addition to Newport, the Lorillard product line has five additional brand families marketed under the Kent®, True®, Maverick®, Old Gold® and Max® brand names. These six brands include 41 different product offerings which vary in price, taste, flavor, length and packaging. Lorillard maintains its headquarters and manufactures all of its products in Greensboro, North Carolina. For more information, visit the Company's web site at www.lorillard.com.
Forward-Looking Statements
Certain statements made in this press release are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, or the Reform Act. Forward-looking statements include, without limitation, any statement that may project, indicate or imply future results, events, performance or achievements, and may contain the words "expect", "intend", "plan", "anticipate", "estimate", "believe", "may", "will be", "will continue", "will likely result", and similar expressions. In addition, any statement that may be provided by management concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible actions by Lorillard, Inc. are also forward-looking statements as defined by the Reform Act.
Forward-looking statements are based on current expectations and projections about future events and are inherently subject to a variety of risks and uncertainties, many of which are beyond our control, that could cause actual results to differ materially from those anticipated or projected. Information describing factors that could cause actual results to differ materially from those in forward-looking statements is available in Lorillard, Inc.'s filings with the Securities and Exchange Commission (the "SEC"), including, but not limited to, our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. These filings are available from the SEC over the Internet or in hard copy, and are available on our website at www.lorillard.com. Forward-looking statements speak only as of the time they are made, and we expressly disclaim any obligation or undertaking to update these statements to reflect any change in expectations or beliefs or any change in events, conditions or circumstances on which any forward-looking statement is based.
Contact: Gregg Perry |
|
(401) 886-7200 |
|
SOURCE Lorillard, Inc.
Share this article